NCT06696235View on ClinicalTrials.gov

Accelerated Vs. Standard Continuous Renal Replacement Therapy for Patients with Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

June 30, 2029

Conditions
Cardiogenic ShockAcute Kidney Injury
Interventions
DEVICE

Early initiation of continuous renal replacement therapy

Patients will be randomized to either the standard initiation of the CRRT group or the accelerated initiation of the CRRT group with a 1:1 ratio.

DEVICE

Standard initiation of continuous renal replacement therapy

Patients will be randomized to either the standard initiation of the CRRT group or the accelerated initiation of the CRRT group with a 1:1 ratio.

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER